Looking back on 2026 investments in the early-stage landscape, experts will pause and analyse where capital went and what it says about the evolution of the life sciences market. Investors will then discuss what decisions they foresee for the year ahead, and how founders and tech transfer teams can adapt to raise capital.
Investment under the microscope: 2026 review and how capital will be allocated in 2027
Home » Investment under the microscope: 2026 review and how capital will be allocated in 2027
2026 Edition
- Track 3
- Day 2
- 2:00 PM
- 3:00 PM
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.